Metraipolis › archive › dc_9bc9e6bf9271
Transcriptional signatures of rapid protection from Sudan virus infection by a single dose of a vesicular stomatitis virus-based vaccine — Europe PMC PMID:41961912
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41961912
- DOI
- 10.1371/journal.ppat.1014143
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T09:19:29.934Z
- SHA-256 of the archived text
407a9f1bf05a9ff31fedecb47903070f3d664130fb562480964682a2987d6a29- Stable URL of this page
https://metraipolis.com/documento/dc_9bc9e6bf9271
How to cite
Transcriptional signatures of rapid protection from Sudan virus infection by a single dose of a vesicular stomatitis virus-based vaccine — Europe PMC PMID:41961912 — Europe PMC (en), https://europepmc.org/article/MED/41961912 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9bc9e6bf9271 (Metraipolis archive dc_9bc9e6bf9271, sha256 407a9f1bf05a9ff31fedecb47903070f3d664130fb562480964682a2987d6a29)
BibTeX
@misc{dc9bc9e6bf9271,
title = {Transcriptional signatures of rapid protection from Sudan virus infection by a single dose of a vesicular stomatitis virus-based vaccine — Europe PMC PMID:41961912},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41961912},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9bc9e6bf9271; sha256 407a9f1bf05a9ff31fedecb47903070f3d664130fb562480964682a2987d6a29},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41961912. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Sudan virus (SUDV) has caused multiple outbreaks of human disease with case fatality rates ranging from 41 to 100%. We have previously shown that a single vaccination with a recombinant vesicular stomatitis virus-based vaccine expressing the SUDV-Gulu glycoprotein (VSV-SUDV) prevented clinical and fatal disease from lethal SUDV challenge in cynomolgus macaques. With the high probability of future outbreaks, it is critical to determine the molecular mechanisms of VSV-SUDV-mediated protection and the ability to impart rapid protection against SUDV infection. In this study, RNA from whole blood samples obtained from nine cynomolgus macaques that were challenged with SUDV-Gulu post-vaccination with either VSV-EBOV (28 days before challenge, n = 3) or VSV-SUDV (28 or 7 days before challenge, n = 3/group) was subjected to bulk RNA sequencing. EdgeR, STEM, MaSigPro, and CIBERSORTx were used to assess longitudinal transcriptional changes elicited by vaccination and challenge. Our analysis revealed that VSV-SUDV and VSV-EBOV elicited distinct transcriptional responses. Moreover, NHPs vaccinated with VSV-EBOV (non-protective) generated a transcriptional response following SUDV challenge indicative of dysregulated inflammation. In contrast, NHPs that received VSV-SUDV vaccine generated a transcriptional response indicative of a recall adaptive immune response. Finally, in-silico deconvolution methods indicated changes in immune cell frequency consistent with immune response and resolution in the VSV-SUDV-vaccinated NHPs that are not observed with VSV-EBOV-vaccinated NHPs. These data indicate that VSV-SUDV vaccination results in a protective humoral response as late as 7 days before challenge despite transcriptional evidence of subclinical features of infection. Tema degli esploratori: scienze della vita e salute (ricerca Europe PMC «immunology», solo open access). Pubblicazione: PLoS pathogens, 2026 (prima pubblicazione 2026-04-10). Identificativi: PMID 41961912 · PMCID PMC13095121 · DOI 10.1371/journal.ppat.1014143. Descrittori MeSH principali: Vesiculovirus; Hemorrhagic Fever, Ebola; Viral Vaccines; Ebolavirus. Pagina: https://europepmc.org/article/MED/41961912 — https://doi.org/10.1371/journal.ppat.1014143. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T08:22:49.736Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.